Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

There is an urgent need for antivirals to treat the newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To identify new candidates, we screen a repurposing library of ∼3,000 drugs. Screening in Vero cells finds few antivirals, while screening in human Huh7.5 cells validates 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Dittmar, Mark, Lee, Jae Seung, Whig, Kanupriya, Segrist, Elisha, Li, Minghua, Kamalia, Brinda, Castellana, Lauren, Ayyanathan, Kasirajan, Cardenas-Diaz, Fabian L., Morrisey, Edward E., Truitt, Rachel, Yang, Wenli, Jurado, Kellie, Samby, Kirandeep, Ramage, Holly, Schultz, David C., Cherry, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2021
Materias:
Resource
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985926/
https://www.ncbi.nlm.nih.gov/pubmed/33811811
http://dx.doi.org/10.1016/j.celrep.2021.108959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985926/
https://www.ncbi.nlm.nih.gov/pubmed/33811811
http://dx.doi.org/10.1016/j.celrep.2021.108959

Ejemplares similares